On the Record

"Small vendors enjoy transparency — that's a model in which they can compete quite aggressively — and the larger vendors would prefer something more opaque."

— Robert Ferraro, R.Ph., a principal at the consulting firm Buck's national pharmacy practice, talked with AIS's RADAR on Drug Benefits about the "pass-through" pricing model, where PBMs will be paid an administrative fee by the Medicaid program and have to pay pharmacists the same amount that they bill the state for drugs.